I have been a bit obsessed with my discovery that a long standing CSR convened study section went through a bad spell. From 2020-2022, NIH funded only seven new (Type 1) R01 per year that were reviewed in this study section. This was a substantial decline from the 22 and 20 grants funded in the […]
